The Compass PRM program and website target patients and their caregivers who have been diagnosed with multiple myeloma or bone metastases from solid tumors, and patients who are diagnosed with cancer. The website includes information about the Compass email program and offers users with an opportunity to sign up and receive a Personalized Doctor Discussion Guide and a series of email communications specific to their situation. Once enrolled, users will receive emails based on whether they are currently on Zometa, diagnosed with bone metastases but not on Zometa, or diagnosed with cancer but not bone metastases.